Media framing xylazine as a “zombie drug” is amplifying stigma onto people who use drugs

Commentary
par
Bowles, Jeannette M., Elizabeth C. Copulsky & Megan K. Reed

Date de publication

2024

Géographie

North America

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

Constatations/points à retenir

People who use drugs are often reluctant to seek medical care due to experiences of medically-institutionalized stigma. Based on the media's extensive depiction of xylazine as the “zombie drug,” it is plausible that medical practitioners have been exposed to this stigmatizing framing, which could unknowingly detrimentally impact provision of medical care. Strategies to offset harms of xylazine-associated stigmas are proposed, including that medical practitioners undergo evidence-based training to reduce stigmatizing responses to severe xylazine-associated ulcers as any indication of enacted stigma can be internalized by the person seeking treatment, which in turn can perpetuate harms like sepsis or overdose.

Mots clés

About prescribers
Stigma